CIB arrives at its May 5 earnings call in a notably different posture than it did three months ago — short sellers have been covering aggressively, the borrow market is loose, and the options market is tilted decidedly toward calls.
The most striking feature of the current setup is the scale of short covering. Short interest has fallen roughly 35% over the past month, dropping from around 1.08 million shares to just under 700,000. That is a meaningful retreat. Days to cover checks in at 2.6 days per the latest exchange data, and the ORTEX short score of 27.3 — the lowest reading in the trailing two-week window — confirms the directional trend. Availability in the lending market is ample, with cost to borrow running below 0.6% annually, well off the highs seen in late March. Bears are not pressing into this print; they appear to be walking away from it.
Options positioning reinforces that picture. The put/call ratio of 0.40 is almost exactly in line with its 20-day average of 0.40 — a z-score near zero signals no unusual hedging demand in either direction. With the 52-week PCR high sitting at 5.85, the current reading is about as benign as it gets. There is no obvious options-driven fear trade ahead of the release.
That calm sits alongside a stock that has drifted lower — down about 5% over the past week and roughly 2% over the past month, closing at $68.19. The RSI at 35 is close to technically oversold territory, which may partly explain why analysts have recently moved in a more constructive direction. UBS lifted its target sharply to $72 on April 23, from $52 previously, while maintaining a Neutral rating — a significant upward revision from a bellwether firm less than two weeks before the print. Goldman Sachs, which upgraded the stock to Neutral from Sell in January and set a $76 target in February, has not walked that back. The analyst consensus currently implies a modest downside of around 5% to the mean target of $63.67, though that figure is dragged down by Itaú BBA's February downgrade to Underperform. The Street is not uniformly positive, but the direction of travel from the biggest names has been upward.
The history around CIB's earnings prints is, however, genuinely sobering. The last two quarterly releases produced single-day declines of 4.8% and 7.6%, with five-day moves of –16% and –18% respectively. The stock has not rewarded buyers of the earnings event in recent history, regardless of what pre-print positioning suggested. The May 5 release will therefore test whether the fundamental narrative — $8.3 billion in estimated revenue, approximately $2 billion in net income, and a forward yield of 7.5% — can finally translate into a reaction that breaks that pattern.
See the live data behind this article on ORTEX.
Open CIB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
